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Abstract.  The intracellular distribution of HIV-1 RNA 
transcripts in infected cells was studied using in situ 
hybridization detected by electron microscopy and cel- 
lular fractionation. Although viral RNA and core pro- 
tein could be detected throughout the cytoplasm and 
nucleus, viral RNA was found in significantly in- 
creased amounts in mitochondria relative to the 
cytoplasm and nucleus. In contrast, cellular poly(A) 
RNA or viral gag proteins were not increased in the 
mitochondria. A cell line containing an integrated la- 
tent genome that could be induced to express viral 
RNA after phorbol ester stimulation showed an in- 
crease in viral RNA accumulation in mitochondria 
parallel with the increase in HIV expression levels. 
Concomitant with HIV expression, there was a de- 
crease in mitochondrial viability. Using immuno- 
fluorescent markers to detect probes to HIV RNA 
transcripts and antibodies to mitochondrial proteins 
simultaneously in single cells, there was an inverse 
relationship between the amount of viral RNA and mi- 
tochondrial integrity.  High levels of viral RNA in mi- 
tochondria were found in acutely (but not chronically) 
infected cells. We propose that HIV RNA import into 
mitochondria can compromise mitochondrial function. 
I 
v is now accepted that HIV-1 infection ofCD4 T lympho- 
cytes results  in a cytopathic effect; however, it is not 
known how this effect is mediated. A number of  hypoth- 
eses have been suggested to explain HIV-l-induced CD4 T 
cell lysis. Fusion of infected cells with uninfected cells (syn- 
cytium formation) was suggested as a mechanism  for cell 
death and depletion ofCD4 T cells in vivo (15, 28). Accumu- 
lation of extrachromosomal HIV DNA in infected cells has 
also been associated with cell death (19, 21). Several investi- 
gators  have  suggested  that  HIV  infection  induces  pro- 
grammed cell death or apoptosis and leads to CD4 depletion 
in vivo (12, 31). Intracellular HIV-gpl60/120 and CD4 com- 
plex formation (9, 11) and cytokine-mediated cell death (17, 
22) have also been implicated in HIV-induced cytopathoge- 
nicity. 
We have investigated the hypothesis that there is a direct 
cytolytic  effect of  HIV RNA (genomic or mRNA transcripts) 
on the infected cell. The dramatic loss of CD4 T cells over 
time after HIV infection may be directly mediated by the 
virus and not secondarily by syncytium-formation or apopto- 
sis. Earlier observations  suggested that HIV infection re- 
suited in cytotoxic effects on individual infected cells in cul- 
ture  (single-cell  killing)  via a  mechanism  involving high 
viral  load (29, 30). Since then,  it has been observed that 
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high quantities of virus are associated with HIV infection in 
vivo (8, 20, 23). The intracellular distribution of HIV tran- 
scripts has been studied directly using in situ hybridization. 
In chronic or acute infection, viral RNA is apparent in the 
nucleus as a primary focus representing the site of  transcrip- 
tion, as well as dispersed throughout the cytoplasm (13). Vi- 
ral RNA signals in acute productive  infection become in- 
tense in the cytoplasm later in infection, before cell lysis. In 
stable producer cell lines, the chronic level of infection re- 
suits in a cytoplasmic signal that is much less, This suggests 
a  relationship  between  cytopathogenecity  and viral  RNA 
levels in the cytoplasm. 
Since viral protein synthesis and virion formation occur at 
sites of HIV RNA accumulation, a high resolution approach 
to intracellular  localization of HIV-1 RNA may reveal the 
cellular sites where the cytopathic effect is manifested. Con- 
centration of  viral RNA within or around specific cellular or- 
ganelles may give insights into the mechanism.  To achieve 
high resolution localization of viral RNA, in situ hybridiza- 
tion was combined with detection by electron microscopy 
(1). Results from this approach showed that high concentra- 
tions of  viral RNA were found preferentially in mitochondria 
relative to the cytoplasm and nucleus. In contrast,  neither 
viral core protein nor poly(A) RNA was increased in the mi- 
tochondria.  Using an inducible cell line (6), HIV RNA was 
observed to traffic into mitochondria  within a short time. 
Import of RNA  into mitochondria  would be expected to 
result from cis-acting sequences in HIV RNA, perhaps in 
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nucleo-mitochondrial pathways for the RNA component of 
the mitochondrial  RNA  processing  (MRP) t endonuclease 
in yeast and mice (2, 14). Import of this RNA into mitochon- 
dria requires cis-acting sequences (14). The accumulation of 
viral RNA in mitochondria would be expected to be dele- 
terious to this organdie. In support of this, a decrease in mi- 
tochondrial  viability  was  observed  concomitant  with  the 
increase in viral RNA in mitochondria. These results sug- 
gested that this mitochondrial concentration of HIV may play 
a role in the cytopathic effect of the virus. 
Materials and Methods 
Mitochondrial Fractionation and Northern Analyses 
Mitochondrial fractions were prepared using a modification of the proce- 
dure described by Topper et al.  (32).  Briefly,  uninfected A3.01 cells and 
chronically infe,  eted HIV-positive ACH2 cells were stimulated with 12-0- 
tetradecanoyl-phorbol-13-acetate (TPA) for 6 h. Before fraetiouation, cells 
were pretreated with RPMI medium containing 10% fetal calf serum, 200 
#g/ml puromycin (to dissociate polysomes), and 10 #g/ml cytochalasin (to 
disrupt aetin filaments) for 15 min at 37"C. All subsequent steps were per- 
formed at 4"C. Cells were washed once in PBS and resuspended in reticulo- 
cyte standard buffer (10 mM Tris-HC1,  pH 7.5;  10 mM NaCI;  1.5 mM 
CaCI2; 4 mM vanadyl ribonucleoside complex) to swell for 15 min. Cells 
were disrupted with a Dounco homogenizer, and an equal volume of 2 x 
mitochondrial standard buffer was added to obtain a final concentration of 
Ix buffer (5 mM Tris-HC1,  pH 7.5; 210 mM mannitol; 70 mM sucrose; 
5 mM EDTA; 4 mM vanadyl ribonucleoside complex). Nuclei and undis- 
rupted ceils were removed by three sequential centrifugations at 1,500 g for 
5 min. The suporuatant was then centrifuged at 8,000 g for 10 rain to obtain 
a mitochondria-enricbed pellet and a cytoplasm-enriched supornatant. The 
pellet was analyzed for mitochondriai purity by standard electron micros- 
copy. RNA was extracted from unfractionated A3.01 cells, ACH2 cells, and 
the mitochondria-enriched pellet, and cytoplasm-enriched fraction using 
guanidinium thioeyanate/phenol method (33). 
To purify the mitochondria further, the mitochondria-enriched  pellet was 
also subjected to Nyeodenz gradient analysis. The pellet was resuspended 
in sucrose-TE buffer (5 mM Tris-HCl, pH 7.5;  250 mM sucrose; 1 mM 
EDTA). This suspension was loaded onto 20--40%  Nycodenz gradient and 
centrifuged at 140,000 g for 90 rain. A total of 13 fractions (100 #1 each) 
were collected and RNA was extracted from each fraction (33). Each frac- 
tion was analyzed by Northern analysis with consecutive 12S rRNA (mito- 
chondria) probe and HIV probe hybridizations, and the counts per min from 
the bands in each lane quantitated by a Beta-scope blot analyzer (Beta-Gen, 
Mountain View, CA). 
Northern analyses were performed according to standard protocol. HIV 
RNA, 12S mitochondriai rRNA and U1 snRNA were analyzed on the same 
RNA blot. HIV-RNA was detected with a 32P-labeled RNA probe that hy- 
bridized to spliced and unspliced HIV messages and was complementary 
to the U3 region of HIV-long terminal repeats (30). The probe to 12S mito- 
chondrial rRNA was a oligoancleotide (40mer), 5' end-labeled with 32p. 
Polymerase chain reaction was used to synthesize [32P]dCTP incorporated 
U1 snRNA probe. 
In Situ Hybridization and Electron 
Microscopic Analyses 
In situ hybridization was performed on HIV-infected cells by the method 
described earlier (26, 27). The full-length (8.9 kb) pHXB-2 HIV DNA (25) 
was biotinylated by nick translation and was used to detect viral RNA. For 
detection, a primary rabbit-antibiotin polyclonal antibody (Enzo Biochem 
Inc., New York) (1 h, 37"C) and a secondary goat-anti-rabbit-IgGl-I nm- 
Au-conjugated antibody (Amersham Corp., Arlington Heights, IL) (2 h, 
37°C) were suspended in BTSSC (1×  SSC, 1% BSA Fraction V [Sigma Im- 
munochemicals, St. Louis, MO], 1% Triton X-100 [Boehringer Mannheim 
GmbH, Mannheim, Germany]) and added to the cells. After antibody incu- 
1. Abbreviations used in this paper: MRP, mitochondrial RNA processing; 
MTT, methyl thiazolyl tetrazolium; TPA,  12-O-tetradecanoyl-phorbol-13- 
acetate. 
bations, the cells were washed with 1×  SSC three times (3 min each). The 
1 nm-Au particles bound to the HIV-1 DNA probe were then silver enhanced 
(Amersham Corp.). Enhancements were monitored on a light microscope 
and stopped when sufficient signal was obtained (usually %10 min). The 
enhancement solution was washed off the cells in water briefly, and the cells 
were dehydrated stepwise in ethanol. Once dehydrated, the cells were em- 
bedded in epon, sectioned, and stained using standard techniques. The vari- 
ation in sizes of  mitochondria observed in the panels were caused by random 
sectioning of cells that resulted in longitudinal or transverse sections of mi- 
tochondria. 
To detect HIV RNA directly in thin sections of cells, cells were embed- 
ded in LR White (5) and viral RNA were detected directly with a novel tech- 
nique using oligonucleotide probes. 20 biotinylated oligonucleotide probes 
(35 mers, five biotins coupled per oligonucleotide) specific to the gag, pol, 
and env regions of HTLV-IIIb  (3 ng/#l probe, 60 ng/~l competitor oligonu- 
cleotides, 50%  formamide, 5% dextran sulfate, 2x  SSC, 20 #1 total vol- 
ume) were incubated on LR White sections of  cells at 37°C for 1 h in a moist 
chamber. After washing the probe in 50% formamide, 2x  SSC once and 
twice in 2×  SSC (20 "dips" each), a primary rabbit-antibiotin polyclonal 
antibody (Enzo Biochem Inc.) (1:100 dilution), and a secondary goat-anti- 
rabbit-IgG1-6  nm-Au-conjugated antibody (Jackson Immunoresearch Lab- 
oratories, Inc., West Grove, PA) were used to detect the hybridized oligonu- 
cleotides. Antibodies were suspended in BTSSC (Ix SSC, 1% BSA Fraction 
V  [Sigma Immunochemicals], 1%  Triton X-100  [Boehringer Mannheim 
GmbH]), and washed off in Ix SSC. Afterwards, the sections were stained 
using concentrated uranyl acetate and Reynold's lead citrate. 
Quantitative and Statistical Analyses of Signals 
(HIV RNA  ) in Electron Micrographs 
Cells were exposed to appropriate reagents and HIV-1 RNA or gag proteins 
detected as described above. Random cells were photographed in the elec- 
tron microscope after sectioning. The photographs of 10 random cells from 
each of several experiments were analyzed under high magnification, and 
the silver grains in cytoplasm (minus mitochondria) and the mitochondria 
were  quantitated  after digitizing the prints  using  a  solid-state charge- 
coupled device camera (Cohu, San Diego, CA). The analyses were done 
using a morphometric computing software (Imagemeasure; Microscience 
Inc., Seattle, WA) along with an interactive scr~n (Werner Frey, Image Lab, 
Santa Monica, CA) and an Equity II computer (Epson America, Inc., Tor- 
rance, CA). Grains were counted manually within each area outlined for 
the computer. Area (in square microns) were computed using internal mark- 
ers and the magnification of the print. The percentage of silver grains within 
mitochondria and the percentage of silver grains outside mitochondria were 
calculated. The density of  grains was determined as the percentage of  grains 
divided by the porcentage of the area. The logt0 of these values were deter- 
mined to be normalized by skew and Kurtosis analyses. A Student's t test 
was performed on these numbers to determine statistical significance (P 
value) of (a) the localization of viral RNA in mitochondria, and (b) in- 
creased levels of viral RNA in mitochondria of acutely infected ceils. Note 
that when counting random cells from acutely infected cultures, some cells 
vary in their levels of viral expression, causing an average that is less than 
that found in highly infected cells. ACI-I2 cells were induced by the phorbol 
ester, TPA, and samples were taken at various times. Cells were analyzed 
for  mitochondriai accumulation  of signal  using the methods described 
above. 
Fluorescent In Situ Hybridization Analyses 
ACH2 cells were stimulated with TPA for 6 h, washed twice in PBS, and 
air dried on gelatin-coated slides. After fixation in 4% paraformaldehyde, 
the cells were washed and HIV RNA was detected by a fluorescent in situ 
hybridization technique using biotinylated HIV-specific probes and avidin- 
FITC as secondary reagent according to previously described procedures 
(26, 27). A monoclonal antibody specific to a 65-kD mitochondriai struc- 
tural protein (Chemicon International, Temecula, CA) was used to stain mi- 
tochondria and goat anti-mouse IgG-TRITC  was used as secondary reagent 
to detect mitochondria. 
Viability Assay for Mitochondria (MTT Assay) 
A fixed number (40,000)  of TPA-induced ACH2 and A3.01 cells from each 
time-point were monitored for viable mitochondria using a colorimetric as- 
say described by Denizot and Lang (3).  The optical density of reduced 
methyl thiazolyl tetrazolium (MTT) dye was measured at 570 run and is 
equivalent to the activity of  dehydrogenase associated with active mitochon- 
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mined as described above. 
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Figure 1. Detection of HIV-I RNA in cytosolic fractions of infected 
cells.  Subcellular  fractionation  and  Northern  analyses  are  de- 
scribed in Materials and Methods. (a) Mitochondrial  12S rRNA, 
HIV RNA, and U1 snRNA were detected by successive Northern 
analyses. Each lane was loaded with 12.3 #g of RNA. Lane 1, total 
cellular RNA from uninfected A3.01 cells (1% of  total); lane 2, total 
Results and Discussion 
HI V RNA Transcripts in Mitochondria 
Previous reports have suggested a role for mitochondria in 
retroviral replication (4, 7, 10). To investigate the intracellu- 
lar distribution of HIV RNA (a member of lentivirus  family 
of retroviruses), a  mitochondria-enriched pellet and cyto- 
plasm-enriched supernatant were prepared from TPA-induced 
ACH2 cells and were analyzed for HIV RNA. Northern blot 
analysis demonstrated the presence of HIV RNA in the mito- 
chondria-enriched pellet and in the cytoplasmic supernatant 
(Fig. 1 a, lanes 3 and 4). The complete mitochondrial pellet 
was analyzed, whereas only '~1% of the other fractions were 
used on the blot to achieve equivalent RNA loading. Lanes 
containing RNA from uninfected A3.01 cells did not hybrid- 
ize to the HIV-specific probe (Fig.  1 a,  lane 1).  To assess 
the quality of mitochondrial and cytoplasmic fractions, the 
same Northern blot was also hybridized to probes specific 
to mitochondrial 12S rRNA and nuclear U1 snRNA.  Frac- 
tions were significantly enriched for mitochondria because 
lane 3  showed high levels of 12S  rRNA  signal  (Fig.  1 a, 
12Spanel). Trace amounts of leakage from the nucleus dur- 
ing disruption were evident in mitochondria-enriched pellet 
because a weak signal for U1 snRNA was observed (Fig.  1 
a,  U1 panel, lanes 3 and 4).  Fig.  1 b represents the mito- 
chondria-enriched pellet analyzed by electron microscopy. 
Contamination from cytoplasmic membrane structures were 
evident.  These analyses  suggested an association of HIV 
transcripts with mitochondrial fractions from infected cells. 
However, to strengthen the observation that a fraction of vi- 
ral RNA was associated with mitochondria, we purified the 
mitochondria-enriched pellet further by Nycodenz gradient- 
density centrifugation. Mitochondria were separated from 
other membrane structures using the 12S rRNA profile as a 
marker. Results showed that HIV RNA was present in the 
first four fractions that contained light membrane structures. 
In addition, HIV RNA (5.5 % of the HIV RNA present in the 
pellet) comigrated with mitochondrial-specific 12S RNA on 
Nycodenz gradients (coinciding peaks of HIV RNA and 12S 
rRNA in Fig.  1 c). 
Viral  RNA  could be  associated  with  mitochondria  in- 
tracellularly or could be inside the organelle itself. To un- 
equivocally demonstrate which of  these occurred, viral RNA 
was visualized directly within thin sections of individual in- 
fected cells. In situ hybridization followed by colloidal gold 
antibodies to detect the biotin-labeled probe was used to oh- 
cellular RNA from TPA-stimulated  ACH2 cells (1% of total); lane 
3,  RNA  from mitochondria-enriched  pellet  of TPA-stimulated 
ACH2 cells (100% of the pellet); lane 4, RNA from cytoplasmic 
supernatant of TPA-stimulated ACH2 cells (1% of total). (b) Elec- 
tron micrograph of the mitochondria-enriched pellet. Bar, 0.5 t~m. 
(c) Comigration of mitochondria (12S rRNA) and HIV RNA by 
Nycodenz sedimentation velocity centrifugation.  Fractions  were 
extracted, electrophoresed, blotted, and probed for 12S rRNA and 
HIV RNA successively. The 32p radioactivity in each lane was 
measured  by  Beta-scope  analysis  instrument  and  expressed  as 
counts per minute. 
Somasundaran et al. HIV-1  RNA in Mitochondria  and Cell Death  1355 Figure 2. Detection and localization of HIV-1 RNA in infected cells using in situ hybridization  and electron microscopy. (a-e) Viral RNA 
was detected by silver-enhanced gold (1) modified as described in Materials and Methods.  (a) c8166 cells infected with HTLV-IIIB. (b) 
8E5 cells. (c) Unstimulated ACH2 cells. (d) ACH2 cells TPA stimulated for 2 h. (e) ACH2 cells TPA stimulated for 6 h. Uninfected cells 
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fected and uninfected cells were inspected initially by light 
microscopy using silver to enhance the gold signal for light 
microscopic resolution and thereby verify the specificity of 
the hybridization only to infected cells. In thin sections, the 
HIV signal was immediately apparent in mitochondria (Fig. 
2, a  and b), as well as in the nucleus and cytoplasm. As a 
control, uninfected or latently infected cells (ACH2 cells) 
(Fig. 2 c) showed no signal. The in situ hybridization pro- 
tocol was somewhat disruptive to cellular membranes; mito- 
chondrial morphology in infected cells showed more effect 
of this than did the mitochondria of uninfected cells, perhaps 
indicating that the presence of viral RNA made their struc- 
ture more fragile. To investigate this further, a protocol was 
developed which preserved the cell by standard ultrastruc- 
ture approaches,  and in situ hybridization was performed 
directly on the thin-sectioned material (5). In this way, the 
embedment preserved and protected the integrity of the or- 
ganene. Chemically biotinylated oligonucleotides were used 
as probes directly on thin sections (Fig. 2 f) since, because 
of their short length (30 nt), their penetration into the em- 
bedment was superior to nick-translated probes (26, 27). By 
this technique, the mitochondria and their cristae were visi- 
ble by a negative stain (Fig. 2 j~ membranes were only par- 
tially extracted), unlike Fig. 2, a-e.  In addition to the mor- 
phologic identification of mitochondria, antibodies specific 
to a mitochondrial structural protein were used to confirm 
the specificity of the antibody for mitochondria (Fig.  2 f, 
inset). 
These initial observations were then subjected to a quan- 
titative analysis on the microscopic images. The distribution 
of silver grains within and outside the mitochondria was de- 
termined and expressed as grain density (percentage of silver 
grains/percentage of area). Results are presented in Table I. 
A positive signal was seen in HIV infected cells, and no sig- 
nal was seen in the control uninfected cells. In addition to 
this, it was evident that mitochondria had concentrated levels 
of HIV RNA, despite the higher amounts of HIV RNA in 
the cytoplasm. The relative ratios of signal (density of silver 
grains)  in mitochondria vs cytoplasm and nucleus ranged 
from 5.6 times (in chronically infected 8E5 cells) to  14.7 
times (in acutely infected c8166 cells). The preferential con- 
centration of HIV-1 RNA in the mitochondria was highly 
significant in both cell types (P < 0.0001). To ensure that this 
concentration in mitochondria was not an artifact of the pro- 
tocol, the distribution in mitochondria of either viral pro- 
teins (gag p24) or of poly(A) RNA was assessed in the same 
manner after in situ hybridization. Viral antigen and poly(A) 
RNA were detected throughout the cell, but not in increased 
concentrations in mitochondria relative to the cytosol, in 
stark contrast to the observation on HIV RNA (Table I). The 
ratio of poly(A) RNA and p24 antigen distribution between 
the mitochondria and the cytoplasm and nucleus was ~,1.2, 
and there was no preferential localization of either of these 
Table L  Quantitation of the Mitochondrial Localization of 
HIV-1 RNA in Acutely Infected or Chronically Infected Cells 
Density of  Density  of 
mitochon-  grains 
drial  outside 
Cell Type  Infection  Probed  for  grains  ~  Ratio 
A3.01  Control  HIV  0.000  0.000  - 
c8166  Acute  HIV  8.761  0.6248  14.7 
8E5  Chronic  HIV  4.376  0.8563  5.63 
8E5  Chronic  Poly A  1.278  0.9912  1.29 
8E5  Chronic  p24  1.233  0.9959  1.24 
in mitochondria (P >  0.5).  These results were consistent 
with an accumulation specifically of viral RNA within the 
mitochondria compared to other RNA or to viral specific 
products. 
The kinetics of viral RNA trafficking into mitochondria 
from sites of nuclear synthesis could be investigated using an 
inducible cell line and provided a time-dependent analysis of 
this mitochondrial import. ACH2 cells, at various times af- 
ter TPA induction, were subjected to EM-in situ hybridiza- 
tion, and the data from the sections were analyzed as de- 
scribed previously. The viral RNA was seen to move rapidly 
into  the  mitochondria.  Shortly  after  induction  by  this 
method, there was detectable viral RNA expression within 
the first hour,  which  continued to increase over the next 
24 h. Eventually, the amount of viral RNA reached concen- 
trations in the mitochondria that are seen in acute infections 
(Fig. 2, d and e; Table II). At all time points, a concomitant 
and highly significant (P < 0.0001) increase in the concentra- 
tion of viral RNA in mitochondria was observed compared 
to the concentration in the cytoplasm and nucleus. These re- 
suits, therefore, demonstrated rapid trafficking of viral RNA 
into mitochondria after activation of HIV-1 expression. This 
occurred as soon as viral RNA expression was detectable in 
the cytoplasm without any evidence of a time lag, or buildup 
in other cellular compartments during the time periods in- 
vestigated. 
Table IL  Quantitation of the Mitochondrial Accumulation 
of HIV-1 RNA as a Function of Time after Induction 
TPA  Density of  Density of grains 
stimulation  mitochondrial  outside 
time  grains  mitochondria  Ratio 
h 
0  0.000  0.2222  0.00 
1  3.762  0.6559  6.78 
2  4.316  0.7523  7.00 
4  3.661  0.6951  5.45 
6  5.255  0.7558  7.29 
12  7.843  0.8248  9.72 
24  8.971  0.7297  12.26 
treated in the same way did not show viral-specific staining; neither did infected cells when they were probed with non-HIV related se- 
quences (not shown). The variation in sizes of mitochondria observed in the panels were caused by random sectioning of cells that resulted 
in longitudinal or transverse sections of mitochondria.  (f) ACH2 cells TPA stimulated for 6 h were processed and viral RNA directly 
detected in thin sections as described in Materials and Methods. (Inset) Immunoeytochemical analysis of uninfected A3.01 cells using 
miiochondrial-specific monoclonal antibody. The arrowheads indicate mitochondria in each panel. Bar, 5 #m. N, nucleus. 
Somasundaran et al. HIV-1 RNA in Mitochondria and Cell  Death  1357 Figure 3. Analysis of HIV-l-positive cells double labeled for a mitochondrial antigen and viral RNA. ACH2 cells TPA stimulated for 6 h 
were washed and air-dried on slides. After fixation in 4% paraformaldehyde, the cells were washed, and HIV RNA was detected by in 
situ hybridization using biotinylated HIV probes and avidin-FITC as secondary reagent. The same cells were stained with mitochondrial- 
specific monoclonal antibody and goat anti-mouse IgG-TRITC was used as secondary reagent. (A) Field of ACH2 cells viewed for FITC 
fluorescence to detect HIV RNA. (B) Same field of cells viewed for TRITC fluorescence to detect cells with viable mitoehondria. The 
arrowheads identify infected cells with high viral expression and diminished mitochondrial staining. The arrows identify a cluster of  infected 
cells with weak viral expression and evident mitochondrial staining. 
Viral Infection Affects Mitochondrial Viability 
HIV RNA sequestration in mitochondria would be expected 
to be deleterious to mitoehondrial function.  To ascertain 
whether high levels of HIV RNA expression could affect mi- 
tochondrial integrity or function, individual TPA-stimulated 
ACH2 cells were analyzed simultaneously for the presence 
of viral RNA (Fig. 3 A) and a mitochondrial structural pro- 
tein (Fig.  3  B) using dual-label fluorescence. The biotin- 
ylated probe was detected by fluorescein-avidin, whereas the 
mitochondria were detected by a rhodamine-conjugated anti- 
body.  Cells  that  showed high  levels of viral RNA  signal 
(green) were  analyzed also  for mitochondrial  signal  and 
had decreased mitochondrial-specific staining (arrowheads). 
Conversely, cells that show a strong signal for mitochondria 
(red)  demonstrated  a  lack of HIV  RNA  signal  (arrows). 
Hence, the mitochondrial antigen is either unavailable, de- 
graded, or dispersed throughout the cytoplasm in cells acutely 
infected with HIV-1. These results are consistent with an in- 
verse correlation between HIV RNA expression and struc- 
tural integrity of mitoehondria. 
To verify that the structurally compromised mitochondria 
were  also  physiologically  compromised,  TPA-stimulated 
ACH2 cells and uninfected A3.01 cells were vitally stained 
with the fluorescent dye, rhodamine 123 (16), which is con- 
centrated by viable mitochondria. Positive cells were quanti- 
tated by fluorescence  intensity. The level of  fluorescent label- 
ing in ACH2 cells decreased from 88 % of normal cells (at 
0 h of TPA stimulation) to 32 % (at 24 h), whereas staining 
of A3.01 T cells remained constant. These results are consis- 
tent with the hypothesis that increases in intracellular HIV 
expression impair mitochondrial functioning. 
To test the effect of viral RNA expression on mitochon- 
drial viability more rigorously, we assayed for mitochondrial 
dehydrogenases in TPA-stimulated ACI-I2 cells.  The assay 
requires intact and functionally viable mitochondria to re- 
duce the tetrazolium dye,3,(4,5-dimethylthiazol-2-yl)2,5 di- 
phenyltetrazoliurn bromide (MTT; 3,18). Low levels of HIV 
RNA expression was detected with 1 h of TPA stimulation 
and levels of viral expression continued to increase with in- 
creasing time of TPA treatment. By 6 h of TPA treatment, 
'~80 % of the cells in culture expressed viral RNA (data not 
shown) and HIV RNA was detected in mitochondria (Fig. 
2 e). No substantial decrease in mitochondrial viability was 
observed (~90% of mitochondria were viable) during this 
period. However, over the next 20 h of TPA treatment, a de- 
crease in mitochondrial enzyme activity was observed in 
ACH2 cells (Fig. 4, open squares) concomitant with increas- 
ing density of mitochondrial-associated viral RNA (Fig. 4, 
open circles) after induction with TPA. Uninfected T  cells 
were assayed in  parallel  for mitochondrial viability after 
TPA treatment (Fig. 4, open triangles),  and no decrease in 
mitochondrial viability was observed. These results further 
support the hypothesis that increases in intracellular HIV ex- 
pression correlates with mitoehondrial dysfunction. 
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Figure 4. Detemunation of the functional  activity of rnitochondria 
in ACH2 cells after st~ulation of viral expression. Mitochondfial 
enzymatic activity was measured in ACH2 cells (open squares) and 
in uninfected A3.01 cells (open triangles) stimulated by the phorbol 
ester, TPA, for various time periods. The density of viral RNA in 
mitochondria of ACH2 cells at each time was determined as de- 
scribed in Materials and Methods (open circles). Total active mito- 
chondria in ACI-I2 cells was inversely related to levels of viral RNA 
accumulation in mitochondria (compare open squares to open cir- 
cles). Mitochondrial activity of unstimulated ACH2 cells and TPA- 
induced uninfected A3.01 cells did not decrease during this period. 
The bars represent standard errors. 
Possibly the loss of mitochondrial viability as a result of 
HIV RNA import correlates with the eventual death of the 
cell. The loss of mitochondrial viability within ACH2 cells 
induced for viral expression preceded cell death by '~24 h, 
as measured by dye exclusion. This suggested that accumula- 
tion of HIV-1 RNA in mitochondria may affect cell viability. 
It might be expected that cell lines propagating a chronic in- 
fection are viable because they have less virus in the mito- 
chondria than acutely infected cells that ultimately undergo 
lysis because of a productive infection producing high levels 
of HIV RNA. Indeed, as demonstrated in Fig. 2 and Table 
I, quantitation of viral RNA by in situ hybridization revealed 
significantly less (P < 0.005) viral RNA in the mitochondria 
of cells from chronic cultures (8E5) compared to cells from 
acute cultures (c8166) (see Table I and Fig. 2, a-c).  These 
results are consistent with the hypothesis that high concen- 
trations of viral RNA could possibly disrupt the normal me- 
tabolism of mitochondria and lead to cell death. 
In summary, five lines of evidence are presented here for 
support of an HIV-mitochondrial interaction: identification 
and copurification of HIV RNA within a mitochondrial frac- 
tion; a time-dependent concentration of  HIV RNA within the 
mitochondria parallel viral RNA expression; disruption of 
mitochondrial integrity as a function of  viral expression; loss 
of mitochondrial viability as a function of viral expression; 
and higher viral RNA  concentrations in  mitochondria of 
acutely infected cells compared to cells with a chronic infec- 
tion. These data support the contention that viral RNA se- 
quences may directly interfere with normal mitochondrial 
function. 
The mechanism by which HIV RNA in mitochondria may 
be toxic is currently unknown. Possibly viral RNA affects 
mitochondrial function by competing with the import ma- 
chinery for nucleic acids or proteins essential for mitochon- 
drial  viability.  A  mechanism for RNA import into mito- 
chondria  exists.  A  RNA  component is  essential  for  the 
functioning of an endoribonuclease (MRP complex), both of 
which are required for mitochondrial RNA processing in 
yeast and mammalian cells (2, 14, 24). Both the protein and 
its associated RNA are nuclear encoded, and they are subse- 
quently imported into mitochondria, presumably as a com- 
plex. Recently, Li et al. have confirmed the existence of an 
RNA-mediated trafficking pathway for MRP-RNA in mouse 
cardiomyocytes using  ultrastructural  in  situ  hybridization 
and biochemical techniques (14).  Using deletion mutants of 
the MRP-RNA gene, they have concluded that specific struc- 
tural determinants within the MRP-RNA were recognized by 
components responsible for mitochondrial import. 
The HIV RNA found in the mitochondria may be imported 
in two possible ways: either a viral factor(s) or a cellular fac- 
tor(s) may transport the RNA in a complex. A candidate for 
the protein component of a transport complex is Rev, which 
is known to redistribute HIV RNA between the nucleus and 
the cytoplasm. Preliminary studies suggest that Rev did not 
interact with human MRP-RNA gene transcripts, nor was it 
found in higher levels in mitochondria, and thus, it may not 
be involved in mitochondrial transport of HIV RNA (data 
not shown). The alternative possibility is that cellular fac- 
tor(s) may bind to viral sequences, such as the Rev-respon- 
sive element, and be involved in the transport mechanism. 
A  comparison between HIV RNA and human MRP-RNA 
did not show sequence homology with the putative import 
sequences (14), but did reveal a region of 27 nt with 67 % ho- 
mology between the end of the viral Rev-responsive element 
and the end of the MRP-RNA.  Currently, work is directed 
toward determining if this region or additional  sequences 
within HIV RNA are responsible for a possible "mistaken 
identity" that may target the HIV RNA to mitochondria. 
Further work will confirm and define the specificity of this 
interaction, and will assist in characterization of the compo- 
nents involved in the nucleo-mitochondrial pathway. 
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